SMARCA5 and cancer: Strikingly, R-loop mutation burden was significantly higher in tumors holding SMARCA4, SMARCA5 and INO80 gene deficiencies (Fig. 5h), consistent with a direct role of these activities preventing R-loop mutagenesis in cancer.